Furthermore, mutations of IDH2 and IDH1 were found in up to 20% of cytogenetically normal acute myeloid leukemia (AML).
Ademais, atopáronse mutacións de IDH2 e IDH1 en ata o 20% dos casos de leucemia mieloide aguda (AML) citoxeneticamente normal.